# Nonuniversality of inflammaging across human populations

- **Journal**: Nature Aging
- **Year**: 2025
- **Type**: Letter
- **Authors**: Maximilien Franck, Kamaryn T. Tanner, Robert L. Tennyson, Camille Daunizeau, Luigi Ferrucci, Stefania Bandinelli, Benjamin C. Trumble, Hillard S. Kaplan, Jacob E. Aronoff, Jonathan Stieglitz, Thomas S. Kraft, Amanda J. Lea, Vivek V. Venkataraman, Ian J. Wallace, Yvonne A. L. Lim, Kee Seong Ng, Joe Poh Sheng Yeong, Roger Ho, Xinru Lim, Ameneh Mehrjerd, Eleftheria G. Charalambous, Allison E. Aiello, Graham Pawelec, Claudio Franceschi, Johannes Hertel, Tamàs Fülöp, Maël Lemoine, Michael Gurven, Alan A. Cohen, et al.
- **Link**: https://www.nature.com/articles/s43587-025-00888-0

## Core idea
An inflammaging axis derived from circulating cytokines in an Italian cohort (InCHIANTI) does not generalize to indigenous populations (Tsimane, Orang Asli) and only partially to another industrialized cohort (Singapore), suggesting that inflammaging—as operationalized here—is largely a byproduct of industrialized lifestyles rather than a universal hallmark.

## Cohorts compared
- InCHIANTI (Italy)
- SLAS (Singapore Longitudinal Aging Study)
- THLHP (Tsimane Health and Life History Project)
- OA HeLP (Orang Asli Health and Lifeways Project)

## Key points
- Axis structure replicates within industrialized datasets (InCHIANTI ↔ SLAS) with notable differences for IL‑6 and IL‑1RA
- Tsimane and Orang Asli show markedly different cytokine factor structures
- Little to no association with age and no consistent associations with age‑related diseases in nonindustrialized cohorts
- Highlights environmental and lifestyle context as critical for interpreting “inflammaging” biomarkers

## Takeaways
- “Inflammaging” is not universal across human populations
- Biomarker-based aging metrics require population- and environment-aware validation
- Precision geroscience should consider diverse ecologies and pathogen exposures when defining inflammatory aging signatures



